Yonhap Infomax NewsSep 23
Daewoong Pharmaceutical disputes a recall order by South Korea’s drug regulator after two acute hepatitis cases linked to its Garcinia supplement, citing alcohol as a confounding factor and calling for a review of ingredient safety.
#YonhapInfomax #DaewoongPharmaceutical #Garcinia #AcuteHepatitis #MFDS #ProductRecall #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=83027
Daewoong Pharmaceutical Faces Regulatory Action Over 'Garcinia' Acute Hepatitis Cases—Company Disputes Food and Drug Safety Ministry's Decision

Daewoong Pharmaceutical disputes a recall order by South Korea’s drug regulator after two acute hepatitis cases linked to its Garcinia supplement, citing alcohol as a confounding factor and calling for a review of ingredient safety.

Yonhap Infomax
Yonhap Infomax NewsJul 23, 2025
South Korea's food safety chief visited CJ CheilJedang's Busan plant to discuss the Import Safety E-Inspection 24 system, highlighting its role in expediting customs clearance and reducing costs for food importers.
#YonhapInfomax #CJCheilJedang #ImportSafetyEInspection24 #MFDS #CustomsClearance #FoodSafetySystem #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=73423
MFDS Chief Visits CJ CheilJedang's Busan Plant—Discusses Import Safety E-Inspection

South Korea's food safety chief visited CJ CheilJedang's Busan plant to discuss the Import Safety E-Inspection 24 system, highlighting its role in expediting customs clearance and reducing costs for food importers.

Yonhap Infomax
Yonhap Infomax NewsApr 8, 2025
GC 녹십자 receives MFDS approval for locally developed anthrax vaccine, enhancing national biodefense capabilities and vaccine sovereignty
#YonhapInfomax #GC녹십자 #AnthraxVaccine #MFDS #Varithrax #BiodefenseCapabilities #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=57751
GC녹십자 Succeeds in Localizing Anthrax Vaccine - MFDS Approval Granted

GC 녹십자 receives MFDS approval for locally developed anthrax vaccine, enhancing national biodefense capabilities and vaccine sovereignty

Yonhap Infomax